Work

Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916.

FWCI: 4.148
Cites:
Cited by: 47
Related to: 10